Wunderlich H, Schlichter A, Reichelt O, Zermann D H, Janitzky V, Kosmehl H, Schubert J
Department of Urology, Friedrich Schiller University, Jena, Germany.
Eur Urol. 1999 Apr;35(4):272-6. doi: 10.1159/000019860.
Adrenalectomy is a part of radical nephrectomy because of the surgical oncology principle of a 'wide margin beyond the malignancy' and due to concern over possible metastases to the ipsilateral adrenal gland, especially in upper pole tumors. But, neither the frequency, predisposing factors of the renal cell carcinoma nor mechanisms of involvement of the adrenal gland are well defined. We assessed the ipsilateral adrenal involvement in renal cell carcinoma to determine whether ipsilateral adrenalectomy during radical nephrectomy is essential.
In a series of 15,347 autopsies in Jena from 1985 through 1996, 272 renal cell carcinoma with 24 adrenal metastases were found. In the same period 9 adrenal metastases were found in 639 radical nephrectomies. Contralateral and bilateral metastases were seen in 15 cases of the autopsy series and in 2 cases of the operative series.
The risk of adrenal metastases correlated with multifocal tumors, pleomorphic cell type, anaplastic growth pattern and tumors that were larger than 2.5 cm. Of the 24 renal cell carcinomas with adrenal metastases in the autopsy series, 23 had evidence of widespread disease and 22 had lymph node metastases. A preoperative abdominal computerized tomography was performed in all 9 patients of the operative series with renal cell carcinoma and adrenal involvement. The adrenal gland was considered abnormal in 8 of the 9 cases (88.9%). Only in 1 patient was the computerized tomography incorrectly interpreted as negative.
We think adrenalectomy should only be performed if there is radiographic evidence of metastases in the adrenal gland or adrenal infiltration by a large upper-pole tumor is possible. Macroscopically normal adrenal glands should not be removed during tumor nephrectomy because the need and benefit of routine adrenalectomy are extremely limited.
肾上腺切除术是根治性肾切除术的一部分,这是基于“恶性肿瘤周围的宽切缘”这一外科肿瘤学原则,同时也是出于对同侧肾上腺可能发生转移的担忧,尤其是对于肾上极肿瘤。但是,肾细胞癌的发生率、易感因素以及肾上腺受累的机制均未得到明确界定。我们评估了肾细胞癌同侧肾上腺受累情况,以确定根治性肾切除术中同期行同侧肾上腺切除术是否必要。
在1985年至1996年于耶拿进行的一系列15347例尸检中,发现272例肾细胞癌伴有24例肾上腺转移。同期,在639例根治性肾切除术中发现9例肾上腺转移。尸检系列中有15例、手术系列中有2例出现对侧及双侧转移。
肾上腺转移风险与多灶性肿瘤、多形细胞类型、间变生长模式以及直径大于2.5 cm的肿瘤相关。尸检系列中24例伴有肾上腺转移的肾细胞癌,23例有广泛病变证据,22例有淋巴结转移。手术系列中所有9例伴有肾细胞癌及肾上腺受累的患者均进行了术前腹部计算机断层扫描。9例中有8例(88.9%)肾上腺被认为异常。仅1例患者的计算机断层扫描被错误解读为阴性。
我们认为,仅当肾上腺有影像学转移证据或肾上极大肿瘤可能浸润肾上腺时,才应行肾上腺切除术。在肿瘤肾切除术中,肉眼外观正常的肾上腺不应被切除,因为常规肾上腺切除术的必要性和益处极其有限。